UPB1
UPB1 (beta-ureidopropionase 1, also known as BUP1) is a cytoplasmic enzyme that catalyses a late step in pyrimidine degradation. It converts N-carbamoyl-beta-alanine into beta-alanine, ammonia and carbon dioxide. Browse Assay Genie's current range of UPB1 research reagents below, or read on for the biology behind the target.
UPB1 catalyses a late step in pyrimidine degradation. The enzyme converts N-carbamoyl-beta-alanine (3-ureidopropanoate) into beta-alanine, ammonia and carbon dioxide. It likewise converts N-carbamoyl-beta-aminoisobutyrate (3-ureidoisobutyrate) into beta-aminoisobutyrate, ammonia and carbon dioxide. The NCBI Gene summary describes it as catalysing the last step of the pathway.
The pyrimidine bases uracil and thymine are degraded by the consecutive action of dihydropyrimidine dehydrogenase, dihydropyrimidinase and beta-ureidopropionase, yielding beta-alanine and beta-aminoisobutyric acid respectively. The UPB1 protein is therefore the final enzyme in this three-step route. It is found in the cytoplasm and belongs to the carbon-nitrogen hydrolase superfamily, within the BUP family.
The UPB1 gene encodes beta-ureidopropionase, formerly named ureidopropionase, beta, and also carries the previous symbol BUP1. Deficiencies in the enzyme are associated with N-carbamyl-beta-amino aciduria and may lead to abnormalities in neurological activity. This makes UPB1 a useful subject for studies of pyrimidine catabolism and inherited disorders of pyrimidine metabolism. Mouse and rat orthologs, both named Upb1, allow comparative work in common model organisms.
UPB1 performs the final step in degrading uracil and thymine to beta-alanine and beta-aminoisobutyric acid, so it is central to studies of this pathway.
UPB1 deficiency is associated with N-carbamyl-beta-amino aciduria, making the enzyme relevant to research on pyrimidine degradation disorders.
Loss of beta-ureidopropionase activity may lead to abnormalities in neurological activity, linking UPB1 to studies of metabolism and the nervous system.
UPB1 hydrolyses both 3-ureidopropanoate and 3-ureidoisobutyrate, offering a model carbon-nitrogen hydrolase for studying substrate handling.
UPB1 is beta-ureidopropionase, which catalyses a late step in pyrimidine degradation. It converts N-carbamoyl-beta-alanine into beta-alanine, ammonia and carbon dioxide, and N-carbamoyl-beta-aminoisobutyrate into beta-aminoisobutyrate, ammonia and carbon dioxide. It acts after dihydropyrimidine dehydrogenase and dihydropyrimidinase.
The HGNC full name is beta-ureidopropionase 1. The protein is also called beta-ureidopropionase, and the gene has the previous symbol BUP1 and the previous name ureidopropionase, beta. The enzyme is classified as EC 3.5.1.6 and belongs to the carbon-nitrogen hydrolase superfamily.
UPB1 deficiency is associated with N-carbamyl-beta-amino aciduria and may lead to abnormalities in neurological activity. Orthologs named Upb1 exist in mouse and rat; check the datasheet of any product for its validated reactivity.
Other pyrimidine metabolism enzymes and carbon-nitrogen hydrolases with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UBR1; product specifications from Assay Genie datasheets.